SlideShare a Scribd company logo
1 of 7
Download to read offline
19 January 2020 For private circulation only
DAILY DERIVATIVE REPORT
20 Jan 2020
Nifty Futures View Volatility FII Activity
Nifty Active Futures 12384.65 India VIX Index 14.12 INDEX FUTURES 130
Nifty Active Futures OI 13602150 Nifty ATM Call IV 8.99 INDEX OPTIONS 489
Change in OI 215100 Nifty ATM Put IV 11.24 STOCK FUTURES -464
Premium / Discount 32.30 PCR Index Options 1.46 STOCK OPTIONS 30
Inference Long Build Up PCR F&O Total 0.98 FII Net Activity 186
NNiiffttyy OOppttiioonnss OOII DDiissttrriibbuuttiioonn HIGHLIGHTS:
Nifty futures closed at 12384.65 on a positive note with 1.61%
increase in open interest indicating Long Build Up.
Nifty Futures closed at a premium of 32 points compared to
previous day premium of 19 points.
BankNifty closed at 31724 on a negative note with 0.19%
decrease in open interest indication Long Unwinding.
BankNifty Futures closed at a premium of 133 points
compared to the previous day premium of 82 points.
FII's were Buyers in Index Futures to the tune of 130 crores
and were Buyers in Index Options to the tune of 489 crores,
Stock Futures were Sellers to the tune of 464 crores. FII's
were Net Buyers in derivative segment to the tune of 186
crores.
India VIX index is at 14.12.Nifty ATM call option IV is currently
at 8.99 whereas Nifty ATM put option IV is quoting at 11.24
NNiiffttyy OOppttiioonnss --CChhaannggee iinn OOII
Index options PCR is at 1.46 and F&O Total PCR is at 0.98.
Among stock futures TORNTPHARMA, BHARTIAIRTEL,
DRREDDY & SRF have witnessed long build up and may
show strength in coming session.
Stock which witnessed short build up are IDEA, IOC, SBIN &
IDFCFIRSTB and may remain weak in coming session.
Nifty Put options OI distribution shows that 12000 has highest
OI concentration followed by 11500 & 12200 which may act as
support for current expiry.
Nifty Call strike 12500 followed by 12400 witnessed significant
OI concentration and may act as resistance for current expiry.
SSEECCUURRIITTIIEESS IINN BBAANN PPEERRIIOODD:: YYEESSBBAANNKK
__________________________________________________________________________________________________________________
SSttoocckk FFuuttuurreess -- LLoonngg BBuuiilldd
____________________________________________________________________________________________________________
SSttoocckk FFuuttuurreess -- SShhoorrtt BBuuiilldd UUpp
Symbol Fut Price % Chg Open Interest % Chg
TORNTPHARM 2016.20 4.22% 387000.00 30.08%
BHARTIARTL 498.60 5.43% 55239393.00 9.83%
DRREDDY 3045.85 3.23% 3454750.00 8.41%
SRF 3638.15 1.37% 849250.00 7.03%
Symbol Fut Price % Chg
Open
Interest
% Chg
IDEA 4.55 -24.79% 488236000.00 13.46%
IOC 122.45 -1.33% 42952000.00 9.99%
SBIN 319.50 -1.62% 123102000.00 9.60%
IDFCFIRSTB 43.60 -3.65% 236928000.00 5.79%
0
100
200
300
400
11900
12000
12100
12200
12300
12400
12500
12600
12700
12800
x10000
Call_oi Put_oi
-60
-40
-20
0
20
40
11900
12000
12100
12200
12300
12400
12500
12600
12700
12800
x10000
Call_chg Put_chg
WEEKLY DERIVATIVE REPORT
Week ended 17th Jan 2020
NNIIFFTTYY HHIIGGHHLLIIGGHHTTSS::
 Nifty Futures has increased by 0.77% to close at 12,384 from previous week close of 12,290.
 Nifty annualized volatility index India Vix has increased to 14.13% from 14.08% up by 0.36%.
 The total open interest (OI) in the Nifty stood at Rs 7,750cr.Where as stock futures OI is at 50,310cr.
 The open interest position of FII in Index Futures is at Rs 13,985Cr and in Stock futures is at Rs 105,171
Cr.
Nifty PCR OI  PCR OI has made a high of 1.68 & low of
1.46 and closed on weekly basis at 1.46
levels.
 PCR OI currently is at 1.46 levels which is
well above the median line indicating that we
will see some cautiousness in Nifty from the
current levels.
OOppeenn IInntteerreesstt AAnnaallyyssiiss
 Options Built up Shows that for now
nifty has strong support at 12,200
followed by 12,000 and resistance at
12,400 levels followed by 12,500.
 12,400 & 12,500 strike call and 12,200 put
followed by 12,000 put has highest open
interest concentration which suggests
that Nifty is likely to trade between this
levels.
CChhaannggee iinn OOppeenn IInntteerreesstt
 This week major addition was seen on the Put
front with 12,300 and 12,400 strikes adding
8.09 and 5.09 lakh in OI respectively.
 On the Call front we have seen addition at
12,500 strike with increase in OI of 2.09 lakh
shares, while unwinding of 3.36 lakh shares
was witnessed in 12,200 strike.
1.00
1.10
1.20
1.30
1.40
1.50
1.60
1.70
1.80
2.50
3.50
4.50
5.50
6.50
7.50
6-Jan
7-Jan
8-Jan
9-Jan
10-Jan
13-Jan
14-Jan
15-Jan
16-Jan
17-Jan
PUTCALLRATIO
OIincr.
Call OI Put OI
0
500,000
1,000,000
1,500,000
2,000,000
2,500,000
3,000,000
3,500,000
4,000,000
11800
11900
12000
12100
12200
12300
12400
12500
12600
12700
12800
12900
13000
OpenInterest
Open Interest Put OI Call OI
-1,000,000
-500,000
0
500,000
1,000,000
11800
11900
12000
12100
12200
12300
12400
12500
12600
12700
12800
12900
13000
OpenInterest
Change in Open Interest Call OI Put OI
WEEKLY DERIVATIVE REPORT
VVoollaattiilliittyy AAnnaallyyssiiss
 IV differential between call and put has
decreased from last week level, which implies
that nifty is most likely to be cautious at
higher levels & may trade with positive bias.
 Call IV’s currently at 9.84%, while Put IV’s are
at 11.34%.
 Implied Volatility of option for the current series is
at 10.58% and has seen downward trajectory in
this week.
WWeeeekkllyy PPaarrttiicciippaanntt WWiissee OOppeenn IInntteerreesstt
Participant
FUT IDX
Long
(contracts)
Net Chg
FUT IDX
Short
(contracts)
Net Chg
Client 125,224 4,416 114,511 -12,696
DII 44,871 -1,468 41,378 7,735
FII 80,919 -2,528 79,939 7,724
Pro 16,849 -1,942 32,035 -4,285
Participant
FUT STK
Long
(contracts)
Net Chg
FUT STK
Short
(contracts)
Net
Chg
Client 756,642 41,355 226,489 15,612
DII 25,488 4,197 1,098,684 2,393
FII 1,017,874 19,278 525,550 40,531
Pro 164,649 18,171 113,930 24,465
FFIIII IInnddeexx FFuuttuurreess
 FII activity in the index futures had been mostly
on the Sell side during this week.
 FII have been net Seller in Index future to the tune
of 1231 crore during this week.
FFIIII SSttoocckk FFuuttuurreess
 FII activity in Stock futures had been on the Sell
side during the last week.
 This week FII have been net Sellers in stock future
segment to the tune 1333 crore.
8.50
9.50
10.50
11.50
12.50
13.50
14.50
15.50
16.50
17.50
6-Jan-
20
7-Jan-
20
8-Jan-
20
9-Jan-
20
10-Jan-
20
13-Jan-
20
14-Jan-
20
15-Jan-
20
16-Jan-
20
17-Jan-
20
Implied volatility(IV) IV Call
Iv Put Historic volatility
152,000
154,000
156,000
158,000
160,000
162,000
164,000
13-Jan 14-Jan 15-Jan 16-Jan 17-Jan
-1,000
-800
-600
-400
-200
0
200
400
InCrores
NET AMT OI IN CONTRACT
1,460,000
1,470,000
1,480,000
1,490,000
1,500,000
1,510,000
1,520,000
1,530,000
1,540,000
1,550,000
13-Jan 14-Jan 15-Jan 16-Jan 17-Jan
-1,000
-800
-600
-400
-200
0
200
400
InCrores
NET AMT OI IN CONTRACT
WEEKLY DERIVATIVE REPORT
SSeeccttoorr WWiissee OOppeenn IInntteerreesstt AAnndd PPrriiccee DDaattaa
WWeeeekkllyy PPrriiccee CChhaannggee WWeeeekkllyy OOII CChhaannggee WWeeeekkllyy PPCCRR CChhaannggee
WWeeeekkllyy OOppeenn IInntteerreesstt GGaaiinneerr WWeeeekkllyy OOppeenn IInntteerreesstt LLoosseerr
Script ID Price % Chg OI Futures % Chg
NTPC 121.15 0.75% 54835200 75.35%
TORNTPHARM 2016.2 5.88% 387000 60.91%
INDUSINDBK 1357.2 -9.21% 17051200 51.27%
RAMCOCEM 823.3 0.30% 1603200 48.01%
TATAGLOBAL 382 11.70% 12673800 39.00%
Script ID Price % Chg OI Futures % Chg
NMDC 130.05 7.13% 21924000 -19.46%
BEL 108.8 11.48% 28902000 -11.04%
JUBLFOOD 1752.05 1.47% 2667000 -9.16%
AMARAJABAT 785.3 6.36% 1446400 -8.13%
HINDUNILVR 2063.45 5.08% 9742500 -7.30%
WWeeeekkllyy PPrriiccee GGaaiinneerr WWeeeekkllyy PPrriiccee LLoosseerr
Script ID Price % Chg OI Futures % Chg
MGL 1142.35 13.44% 2281200 6.95%
IGL 471.15 12.88% 9894500 16.40%
PEL 1634.55 12.43% 5478879 18.97%
TATAGLOBAL 382 11.70% 12673800 39.00%
BEL 108.8 11.48% 28902000 -11.04%
Script ID Price % Chg OI Futures % Chg
IDEA 4.55 -25.41% 488236000 12.36%
INFRATEL 219 -11.76% 14692000 7.73%
INDUSINDBK 1357.2 -9.21% 17051200 51.27%
YESBANK 37.75 -6.79% 305685600 17.35%
MOTHERSUMI 140.25 -5.94% 32245000 -0.75%
0.06%
1.69%
-1.86%
6.94%
2.46%
0.52%
3.46%
3.11%
2.27%
2.56%
3.07%
4.61%
4.12%
1.96%
2.11%
0.15%
4.75%
3.40%
8.49%
Wkly Price change
Textile
Fertilisers
Oil_Gas
Cement
Capital_Good
s
Media
FMCG
Pharma
Automobile
Infrastructure
Finance
Others
Power
Metals
Technology
Realty
Banking
Telecom
Index
0.70%
21.31%
5.63%
4.37%
4.50%
2.47%
20.62%
6.95%
3.58%
7.26%
2.50%
10.70%
5.16%
4.17%
3.48%
3.28%
5.26%
6.12%
11.91%
Wkly OI change
Textile
Fertilisers
Oil_Gas
Cement
Capital_Good
s
Media
FMCG
Pharma
Automobile
Infrastructure
Finance
Others
Power
Metals
Technology
Realty
Banking
Telecom
Index
1.33%
3.01%
3.02%
2.39%
0.76%
2.13%
0.51%
1.44%
1.12%
1.23%
1.39%
1.53%
1.68%
0.34%
2.19%
0.63%
2.70%
1.17%
2.09%
Wkly Roll Over change
Textile
Fertilisers
Oil_Gas
Cement
Capital_Good
s
Media
FMCG
Pharma
Automobile
Infrastructure
Finance
Others
Power
Metals
Technology
Realty
Banking
Telecom
Index
WEEKLY DERIVATIVE REPORT
SSttoocckk wwiissee OOppeenn IInntteerreesstt DDiissttrriibbuuttiioonn iinn BBaannkkiinngg SSeeccttoorr
BBaannkk NNiiffttyy OOppeenn IInntteerreesstt ffoorr PPSSUU BBaannkkss VV//ss PPrriivvaattee BBaannkkss
BBaannkk NNiiffttyy SSttrriikkee wwiissee ooppeenn iinntteerreesstt ddiissttrriibbuuttiioonn
RBLBANK, ICICIBANK and INDUSINDBNK can see some NEGATIVE move in this week.
Bank Nifty has a very strong support at 31,500, as 31,500 PE strike is having highest OI concentration
followed by 31,000 and on the Call front 32,000 CE strike has highest OI concentration indicating strong
resistance level followed by 32,500.
AXISBANK
BANKBARODA
CANBK FEDERALBNK
HDFCBANK
ICICIBANK
IDFCFIRSTB
INDUSINDBKKOTAKBANK
PNB, 10%
RBLBANK
SBIN, 11%
YESBANK
29%
71%
Open Interest
Psu Bank Private Bank
0
100,000
200,000
300,000
400,000
500,000
600,000
30600
30700
30800
30900
31000
31100
31200
31300
31400
31500
31600
31700
31800
31900
32000
32100
32200
32300
32400
32500
32600
OpenInterest
Open Interest Call OI Put OI
WEEKLY DERIVATIVE REPORT
Disclosures:
The following Disclosures are being made in compliance with the SEBI Research Analyst Regulations 2014 (herein after referred to as the
Regulations).
1. Axis Securities Ltd. (ASL) is a SEBI Registered Research Analyst having registration no. INH000000297. ASL, the Research Entity (RE) as
defined in the Regulations, is engaged in the business of providing Stock broking services, Depository participant services & distribution
of various financial products. ASL is a subsidiary company of Axis Bank Ltd. Axis Bank Ltd. is a listed public company and one of India’s
largest private sector bank and has its various subsidiaries engaged in businesses of Asset management, NBFC, Merchant Banking,
Trusteeship, Venture Capital, Stock Broking, the details in respect of which are available on www.axisbank.com.
2. ASL is registered with the Securities & Exchange Board of India (SEBI) for its stock broking & Depository participant business activities
and with the Association of Mutual Funds of India (AMFI) for distribution of financial products and also registered with IRDA as a
corporate agent for insurance business activity.
3. ASL has no material adverse disciplinary history as on the date of publication of this report.
4. I/We, authors (Research team) and the name/s subscribed to this report, hereby certify that all of the views expressed in this research
report accurately reflect my/our views about the subject issuer(s) or securities. I/We also certify that no part of my/our compensation was,
is, or will be directly or indirectly related to the specific recommendation(s) or view(s) in this report. I/we or my/our relative or ASL does
not have any financial interest in the subject company. Also I/we or my/our relative or ASL or its Associates may have beneficial
ownership of 1% or more in the subject company at the end of the month immediately preceding the date of publication of the Research
Report. Since associates of ASL are engaged in various financial service businesses, they might have financial interests or beneficial
ownership in various companies including the subject company/companies mentioned in this report. I/we or my/our relative or ASL or its
associate does not have any material conflict of interest. I/we have not served as director / officer, etc. in the subject company in the last 12-
month period.
Research Team
Sr. No Name Designation E-mail
1 Rajesh Palviya Technical & DerivativeAnalyst - (Head) rajesh.palviya@axissecurities.in
2 Vaishnavi Jagtap Technical Analyst vaishnavi.jagtap@axissecurities.in
3 Hemang Gor Derivative Analyst hemang.gor@axissecurities.in
4 Rahil.vora Derivative Analyst Rahil.vora@axissecurities.in
5 Hiren Trivedi Research Associate hiren.trivedi@axissecurities.in
6 Kiran Gawle Associate kiran.gawle@axissecurities.in
5. ASL has not received any compensation from the subject company in the past twelve months. ASL has not been engaged in market
making activity for the subject company.
6. In the last 12-month period ending on the last day of the month immediately preceding the date of publication of this research report,
ASL or any of its associates may have:
i. Received compensation for investment banking, merchant banking or stock broking services or for any other services from the
subject company of this research report and / or;
ii. Managed or co-managed public offering of the securities from the subject company of this research report and / or;
iii. Received compensation for products or services other than investment banking, merchant banking or stock broking services
from the subject company of this research report;
ASL or any of its associates have not received compensation or other benefits from the subject company of this research report or any other
third-party in connection with this report
Term& Conditions:
This report has been prepared by ASL and is meant for sole use by the recipient and not for circulation. The report and information
contained herein is strictly confidential and may not be altered in any way, transmitted to, copied or distributed, in part or in whole, to any
other person or to the media or reproduced in any form, without prior written consent of ASL. The report is based on the facts, figures and
information that are considered true, correct, reliable and accurate. The intent of this report is not recommendatory in nature. The
information is obtained from publicly available media or other sources believed to be reliable. Such information has not been independently
verified and no guaranty, representation of warranty, express or implied, is made as to its accuracy, completeness or correctness. All such
information and opinions are subject to change without notice. The report is prepared solely for informational purpose and does not
constitute an offer document or solicitation of offer to buy or sell or subscribe for securities or other financial instruments for the clients.
Though disseminated to all the customers simultaneously, not all customers may receive this report at the same time. ASL will not treat
recipients as customers by virtue of their receiving this report.
WEEKLY DERIVATIVE REPORT
Disclaimer:
Nothing in this report constitutes investment, legal, accounting and tax advice or a representation that any investment or strategy is suitable
or appropriate to the recipient’s specific circumstances. The securities and strategies discussed and opinions expressed, if any, in this report
may not be suitable for all investors, who must make their own investment decisions, based on their own investment objectives, financial
positions and needs of specific recipient.
This report may not be taken in substitution for the exercise of independent judgment by any recipient. Each recipient of this report should
make such investigations as it deems necessary to arrive at an independent evaluation of an investment in the securities of companies
referred to in this report (including the merits and risks involved), and should consult its own advisors to determine the merits and risks of
such an investment. Certain transactions, including those involving futures, options and other derivatives as well as non-investment grade
securities involve substantial risk and are not suitable for all investors. ASL, its directors, analysts or employees do not take any
responsibility, financial or otherwise, of the losses or the damages sustained due to the investments made or any action taken on basis of this
report, including but not restricted to, fluctuation in the prices of shares and bonds, changes in the currency rates, diminution in the NAVs,
reduction in the dividend or income, etc. Past performance is not necessarily a guide to future performance. Investors are advise necessarily
a guide to future performance. Investors are advised to see Risk Disclosure Document to understand the risks associated before investing in
the securities markets. Actual results may differ materially from those set forth in projections. Forward-looking statements are not
predictions and may be subject to change without notice.
ASL and its affiliated companies, their directors and employees may; (a) from time to time, have long or short position(s) in, and buy or sell
the securities of the company(ies) mentioned herein or (b) be engaged in any other transaction involving such securities or earn brokerage or
other compensation or act as a market maker in the financial instruments of the company(ies) discussed herein or act as an advisor or
investment banker, lender/borrower to such company(ies) or may have any other potential conflict of interests with respect to any
recommendation and other related information and opinions. Each of these entities functions as a separate, distinct and independent of each
other. The recipient should take this into account before interpreting this document.
ASL and / or its affiliates do and seek to do business including investment banking with companies covered in its research reports. As a
result, the recipients of this report should be aware that ASL may have a potential conflict of interest that may affect the objectivity of this
report. Compensation of Research Analysts is not based on any specific merchant banking, investment banking or brokerage service
transactions. ASL may have issued other reports that are inconsistent with and reach different conclusion from the information presented in
this report.
Neither this report nor any copy of it may be taken or transmitted into the United State (to U.S. Persons), Canada, or Japan or distributed,
directly or indirectly, in the United States or Canada or distributed or redistributed in Japan or to any resident thereof. If this report is
inadvertently sent or has reached any individual in such country, especially, USA, the same may be ignored and brought to the attention of
the sender. This report is not directed or intended for distribution to, or use by, any person or entity who is a citizen or resident of or located
in any locality, state, country or other jurisdiction, where such distribution, publication, availability or use would be contrary to law,
regulation or which would subject ASL to any registration or licensing requirement within such jurisdiction. The securities described herein
may or may not be eligible for sale in all jurisdictions or to certain category of investors.
The Disclosures of Interest Statement incorporated in this document is provided solely to enhance the transparency and should not be
treated as endorsement of the views expressed in the report. The Company reserves the right to make modifications and alternations to this
document as may be required from time to time without any prior notice. The views expressed are those of the analyst(s) and the Company
may or may not subscribe to all the views expressed therein.
Copyright in this document vests with Axis Securities Limited.
Axis Securities Limited, SEBI Single Reg. No.- NSE, BSE & MSEI – INZ000161633, ARN No. 64610, CDSL-IN-DP-CDSL-693-2013, SEBI-
Research Analyst Reg. No. INH 000000297, SEBI Portfolio Manager Reg. No.- INP000000654, Main/Dealing off.- Unit No. 2, Phoenix Market
City, 15, LBS Road, Near Kamani Junction, Kurla (west), Mumbai-400070, Tel No. – 18002100808, Reg. off.- Axis House, 8th Floor, Wadia
International Centre, Pandurang Budhkar Marg, Worli, Mumbai – 400 025.Compliance Officer: Anand Shaha, E-Mail ID:
compliance.officer@axisdirect.in,Tel No: 022-42671582.

More Related Content

What's hot

Derivatives Report - July 16, 2010
Derivatives Report - July 16, 2010Derivatives Report - July 16, 2010
Derivatives Report - July 16, 2010
Angel Broking
 
Derivatives report 24 may-2010
Derivatives report 24 may-2010Derivatives report 24 may-2010
Derivatives report 24 may-2010
Angel Broking
 
Derivatives Report - August 1, 2010
Derivatives Report - August 1, 2010Derivatives Report - August 1, 2010
Derivatives Report - August 1, 2010
Angel Broking
 
Derivatives Report - September 21, 2010
Derivatives Report - September 21, 2010Derivatives Report - September 21, 2010
Derivatives Report - September 21, 2010
Angel Broking
 

What's hot (15)

Weekly Derivatives Report :08 July 2019
Weekly Derivatives Report :08 July 2019Weekly Derivatives Report :08 July 2019
Weekly Derivatives Report :08 July 2019
 
Equity Research Report 02 November 2016 Ways2Capital
Equity Research Report 02 November 2016 Ways2CapitalEquity Research Report 02 November 2016 Ways2Capital
Equity Research Report 02 November 2016 Ways2Capital
 
Weekly Derivatives Report :16 December 2019
Weekly Derivatives Report :16 December 2019Weekly Derivatives Report :16 December 2019
Weekly Derivatives Report :16 December 2019
 
Equity research report 29 february 2016 Ways2Capital
Equity research report 29 february 2016 Ways2CapitalEquity research report 29 february 2016 Ways2Capital
Equity research report 29 february 2016 Ways2Capital
 
Weekly Derivatives Report :23 September 2019
Weekly Derivatives Report :23 September 2019Weekly Derivatives Report :23 September 2019
Weekly Derivatives Report :23 September 2019
 
Weekly Derivatives Report :13 August 2019
Weekly Derivatives Report :13 August 2019Weekly Derivatives Report :13 August 2019
Weekly Derivatives Report :13 August 2019
 
Weekly Derivatives Report :11 November 2019
Weekly Derivatives Report :11 November 2019Weekly Derivatives Report :11 November 2019
Weekly Derivatives Report :11 November 2019
 
Weekly Derivatives Report :16 September 2019
Weekly Derivatives Report :16 September 2019Weekly Derivatives Report :16 September 2019
Weekly Derivatives Report :16 September 2019
 
Derivatives Report - July 16, 2010
Derivatives Report - July 16, 2010Derivatives Report - July 16, 2010
Derivatives Report - July 16, 2010
 
Epicresearch daily derivatives market report on 24 february 2015
Epicresearch daily derivatives market report on 24 february 2015Epicresearch daily derivatives market report on 24 february 2015
Epicresearch daily derivatives market report on 24 february 2015
 
Equity Research Report 19 June 2017 Ways2Capital
Equity Research Report 19 June 2017 Ways2CapitalEquity Research Report 19 June 2017 Ways2Capital
Equity Research Report 19 June 2017 Ways2Capital
 
Derivatives report 24 may-2010
Derivatives report 24 may-2010Derivatives report 24 may-2010
Derivatives report 24 may-2010
 
Derivatives Report - August 1, 2010
Derivatives Report - August 1, 2010Derivatives Report - August 1, 2010
Derivatives Report - August 1, 2010
 
Derivatives Report - September 21, 2010
Derivatives Report - September 21, 2010Derivatives Report - September 21, 2010
Derivatives Report - September 21, 2010
 
Equity research report 04 july 2016 Ways2Capital
Equity research report 04 july 2016 Ways2CapitalEquity research report 04 july 2016 Ways2Capital
Equity research report 04 july 2016 Ways2Capital
 

Similar to Weekly Derivatives Report :20 January 2020

Similar to Weekly Derivatives Report :20 January 2020 (20)

Weekly Derivatives Report :09 December 2019
Weekly Derivatives Report :09 December 2019Weekly Derivatives Report :09 December 2019
Weekly Derivatives Report :09 December 2019
 
Weekly Derivatives Report :14 October 2019
Weekly Derivatives Report :14 October 2019Weekly Derivatives Report :14 October 2019
Weekly Derivatives Report :14 October 2019
 
Weekly Derivatives Report :25 March 2019
Weekly Derivatives Report :25 March 2019Weekly Derivatives Report :25 March 2019
Weekly Derivatives Report :25 March 2019
 
Weekly Derivatives Report :07 October 2019
Weekly Derivatives Report :07 October 2019Weekly Derivatives Report :07 October 2019
Weekly Derivatives Report :07 October 2019
 
Weekly Derivatives Report :19 August 2019
Weekly Derivatives Report :19 August 2019Weekly Derivatives Report :19 August 2019
Weekly Derivatives Report :19 August 2019
 
Weekly Derivatives Report :25 February 2019
Weekly Derivatives Report :25 February 2019Weekly Derivatives Report :25 February 2019
Weekly Derivatives Report :25 February 2019
 
Weekly Derivatives Report :22 October 2019
Weekly Derivatives Report :22 October 2019Weekly Derivatives Report :22 October 2019
Weekly Derivatives Report :22 October 2019
 
Weekly Derivatives Report :26 November 2018
Weekly Derivatives Report :26 November 2018Weekly Derivatives Report :26 November 2018
Weekly Derivatives Report :26 November 2018
 
Epicresearch daily derivatives report on 13 february 2015
Epicresearch daily derivatives report on 13 february 2015Epicresearch daily derivatives report on 13 february 2015
Epicresearch daily derivatives report on 13 february 2015
 
Equity Research Report 09 November 2015 Ways2Capital
Equity Research Report 09 November 2015 Ways2CapitalEquity Research Report 09 November 2015 Ways2Capital
Equity Research Report 09 November 2015 Ways2Capital
 
Equity Research Report 17 October 2016 Ways2Capital
Equity Research Report 17 October 2016 Ways2CapitalEquity Research Report 17 October 2016 Ways2Capital
Equity Research Report 17 October 2016 Ways2Capital
 
Equity Research Report 14 December 2015 Ways2Capital
Equity Research Report 14 December 2015 Ways2CapitalEquity Research Report 14 December 2015 Ways2Capital
Equity Research Report 14 December 2015 Ways2Capital
 
Equity Research Report 18 july 2016 Ways2Capital
Equity Research Report 18 july 2016 Ways2CapitalEquity Research Report 18 july 2016 Ways2Capital
Equity Research Report 18 july 2016 Ways2Capital
 
Equity Research Report 17 july 2016 Ways2Capital
Equity Research Report 17 july 2016 Ways2CapitalEquity Research Report 17 july 2016 Ways2Capital
Equity Research Report 17 july 2016 Ways2Capital
 
Epic research weekly derivative report 17 august 2015
Epic research weekly derivative report 17 august 2015Epic research weekly derivative report 17 august 2015
Epic research weekly derivative report 17 august 2015
 
Equity Research Report 22 August 2016 Ways2Capital
Equity Research Report 22 August 2016 Ways2CapitalEquity Research Report 22 August 2016 Ways2Capital
Equity Research Report 22 August 2016 Ways2Capital
 
Epic research's weekly derivative market report 26th september 2016
Epic research's weekly derivative market report 26th september 2016Epic research's weekly derivative market report 26th september 2016
Epic research's weekly derivative market report 26th september 2016
 
Epic research's daily derivative market report 14th june 2016
Epic research's daily derivative market report 14th june 2016Epic research's daily derivative market report 14th june 2016
Epic research's daily derivative market report 14th june 2016
 
Epic research weekly derivative report 3 august 2015
Epic research weekly derivative report 3 august 2015Epic research weekly derivative report 3 august 2015
Epic research weekly derivative report 3 august 2015
 
Epic research's daily derivative market report 28th april 2016
Epic research's daily derivative market report 28th april 2016Epic research's daily derivative market report 28th april 2016
Epic research's daily derivative market report 28th april 2016
 

More from Axis Direct

More from Axis Direct (20)

Daily Technical Report:30 March 2020
Daily Technical Report:30 March 2020Daily Technical Report:30 March 2020
Daily Technical Report:30 March 2020
 
Daily Derivatives Report:30 March 2020
Daily Derivatives Report:30 March 2020Daily Derivatives Report:30 March 2020
Daily Derivatives Report:30 March 2020
 
Daily Derivatives Report:27 March 2020
Daily Derivatives Report:27 March 2020Daily Derivatives Report:27 March 2020
Daily Derivatives Report:27 March 2020
 
Daily Technical Report:27 March 2020
Daily Technical Report:27 March 2020Daily Technical Report:27 March 2020
Daily Technical Report:27 March 2020
 
Daily Derivatives Report:26 March 2020
Daily Derivatives Report:26 March 2020Daily Derivatives Report:26 March 2020
Daily Derivatives Report:26 March 2020
 
Daily Technical Report:26 March 2020
Daily Technical Report:26 March 2020Daily Technical Report:26 March 2020
Daily Technical Report:26 March 2020
 
Daily Derivatives Report:25 March 2020
Daily Derivatives Report:25 March 2020Daily Derivatives Report:25 March 2020
Daily Derivatives Report:25 March 2020
 
Daily Technical Report:25 March 2020
Daily Technical Report:25 March 2020Daily Technical Report:25 March 2020
Daily Technical Report:25 March 2020
 
Daily Derivatives Report:24 March 2020
Daily Derivatives Report:24 March 2020Daily Derivatives Report:24 March 2020
Daily Derivatives Report:24 March 2020
 
Daily Technical Report:24 March 2020
Daily Technical Report:24 March 2020Daily Technical Report:24 March 2020
Daily Technical Report:24 March 2020
 
Daily Technical Report:23 March 2020
Daily Technical Report:23 March 2020Daily Technical Report:23 March 2020
Daily Technical Report:23 March 2020
 
Daily Derivatives Report:20 March 2020
Daily Derivatives Report:20 March 2020Daily Derivatives Report:20 March 2020
Daily Derivatives Report:20 March 2020
 
Daily Technical Report:20 March 2020
Daily Technical Report:20 March 2020Daily Technical Report:20 March 2020
Daily Technical Report:20 March 2020
 
Daily Derivatives Report:19 March 2020
Daily Derivatives Report:19 March 2020Daily Derivatives Report:19 March 2020
Daily Derivatives Report:19 March 2020
 
Daily Technical Report:19 March 2020
Daily Technical Report:19 March 2020Daily Technical Report:19 March 2020
Daily Technical Report:19 March 2020
 
Daily Technical Report:18 March 2020
Daily Technical Report:18 March 2020Daily Technical Report:18 March 2020
Daily Technical Report:18 March 2020
 
Daily Derivatives Report:18 March 2020
Daily Derivatives Report:18 March 2020Daily Derivatives Report:18 March 2020
Daily Derivatives Report:18 March 2020
 
Daily Technical Report:17 March 2020
Daily Technical Report:17 March 2020Daily Technical Report:17 March 2020
Daily Technical Report:17 March 2020
 
Daily Derivatives Report:17 March 2020
Daily Derivatives Report:17 March 2020Daily Derivatives Report:17 March 2020
Daily Derivatives Report:17 March 2020
 
Daily Derivatives Report:13 March 2020
Daily Derivatives Report:13 March 2020Daily Derivatives Report:13 March 2020
Daily Derivatives Report:13 March 2020
 

Recently uploaded

💊💊 OBAT PENGGUGUR KANDUNGAN JAMBI 08776558899 ATAU CARA GUGURKAN JANIN KLINIK...
💊💊 OBAT PENGGUGUR KANDUNGAN JAMBI 08776558899 ATAU CARA GUGURKAN JANIN KLINIK...💊💊 OBAT PENGGUGUR KANDUNGAN JAMBI 08776558899 ATAU CARA GUGURKAN JANIN KLINIK...
💊💊 OBAT PENGGUGUR KANDUNGAN JAMBI 08776558899 ATAU CARA GUGURKAN JANIN KLINIK...
Cara Menggugurkan Kandungan 087776558899
 

Recently uploaded (10)

Namakkal ❤CALL GIRL 84099*07087 ❤CALL GIRLS IN Namakkal ESCORT SERVICE❤CALL GIRL
Namakkal ❤CALL GIRL 84099*07087 ❤CALL GIRLS IN Namakkal ESCORT SERVICE❤CALL GIRLNamakkal ❤CALL GIRL 84099*07087 ❤CALL GIRLS IN Namakkal ESCORT SERVICE❤CALL GIRL
Namakkal ❤CALL GIRL 84099*07087 ❤CALL GIRLS IN Namakkal ESCORT SERVICE❤CALL GIRL
 
KENDUJHAR ODIA CALL GIRL SEIRVEC ❣️ 72051//37929❣️ CALL GIRL IN ODIA HAND TO ...
KENDUJHAR ODIA CALL GIRL SEIRVEC ❣️ 72051//37929❣️ CALL GIRL IN ODIA HAND TO ...KENDUJHAR ODIA CALL GIRL SEIRVEC ❣️ 72051//37929❣️ CALL GIRL IN ODIA HAND TO ...
KENDUJHAR ODIA CALL GIRL SEIRVEC ❣️ 72051//37929❣️ CALL GIRL IN ODIA HAND TO ...
 
Prince Armahs(Tinky) Brochure, for Funeral service
Prince Armahs(Tinky) Brochure, for Funeral servicePrince Armahs(Tinky) Brochure, for Funeral service
Prince Armahs(Tinky) Brochure, for Funeral service
 
9565589233 Whatsapp Free Nude Video Call Service Porn Girls Porn Videos
9565589233 Whatsapp Free Nude Video Call Service Porn Girls Porn Videos9565589233 Whatsapp Free Nude Video Call Service Porn Girls Porn Videos
9565589233 Whatsapp Free Nude Video Call Service Porn Girls Porn Videos
 
💊💊 OBAT PENGGUGUR KANDUNGAN JAMBI 08776558899 ATAU CARA GUGURKAN JANIN KLINIK...
💊💊 OBAT PENGGUGUR KANDUNGAN JAMBI 08776558899 ATAU CARA GUGURKAN JANIN KLINIK...💊💊 OBAT PENGGUGUR KANDUNGAN JAMBI 08776558899 ATAU CARA GUGURKAN JANIN KLINIK...
💊💊 OBAT PENGGUGUR KANDUNGAN JAMBI 08776558899 ATAU CARA GUGURKAN JANIN KLINIK...
 
BHADRAK Call Girls JAMSHEDPUR Just Call 93480*64116 Top Class Call Girl Servi...
BHADRAK Call Girls JAMSHEDPUR Just Call 93480*64116 Top Class Call Girl Servi...BHADRAK Call Girls JAMSHEDPUR Just Call 93480*64116 Top Class Call Girl Servi...
BHADRAK Call Girls JAMSHEDPUR Just Call 93480*64116 Top Class Call Girl Servi...
 
Hosur ❤CALL GIRL 84099*07087 ❤CALL GIRLS IN Hosur ESCORT SERVICE❤CALL GIRL
Hosur ❤CALL GIRL 84099*07087 ❤CALL GIRLS IN Hosur ESCORT SERVICE❤CALL GIRLHosur ❤CALL GIRL 84099*07087 ❤CALL GIRLS IN Hosur ESCORT SERVICE❤CALL GIRL
Hosur ❤CALL GIRL 84099*07087 ❤CALL GIRLS IN Hosur ESCORT SERVICE❤CALL GIRL
 
BERHAMPUR Call Girls JAMSHEDPUR Just Call 93480*64116 Top Class Call Girl Ser...
BERHAMPUR Call Girls JAMSHEDPUR Just Call 93480*64116 Top Class Call Girl Ser...BERHAMPUR Call Girls JAMSHEDPUR Just Call 93480*64116 Top Class Call Girl Ser...
BERHAMPUR Call Girls JAMSHEDPUR Just Call 93480*64116 Top Class Call Girl Ser...
 
BHUBANESWAR CALL GIRL IN SEIRVEC ODIA ❣️72051SIYA37929❣️ CASH PAYMENT ONLY CA...
BHUBANESWAR CALL GIRL IN SEIRVEC ODIA ❣️72051SIYA37929❣️ CASH PAYMENT ONLY CA...BHUBANESWAR CALL GIRL IN SEIRVEC ODIA ❣️72051SIYA37929❣️ CASH PAYMENT ONLY CA...
BHUBANESWAR CALL GIRL IN SEIRVEC ODIA ❣️72051SIYA37929❣️ CASH PAYMENT ONLY CA...
 
KHORDHA ODIA CALL GIRL SEIRVEC ❣️ 72051//37929❣️ CALL GIRL IN ODIA HAND TO HA...
KHORDHA ODIA CALL GIRL SEIRVEC ❣️ 72051//37929❣️ CALL GIRL IN ODIA HAND TO HA...KHORDHA ODIA CALL GIRL SEIRVEC ❣️ 72051//37929❣️ CALL GIRL IN ODIA HAND TO HA...
KHORDHA ODIA CALL GIRL SEIRVEC ❣️ 72051//37929❣️ CALL GIRL IN ODIA HAND TO HA...
 

Weekly Derivatives Report :20 January 2020

  • 1. 19 January 2020 For private circulation only DAILY DERIVATIVE REPORT 20 Jan 2020 Nifty Futures View Volatility FII Activity Nifty Active Futures 12384.65 India VIX Index 14.12 INDEX FUTURES 130 Nifty Active Futures OI 13602150 Nifty ATM Call IV 8.99 INDEX OPTIONS 489 Change in OI 215100 Nifty ATM Put IV 11.24 STOCK FUTURES -464 Premium / Discount 32.30 PCR Index Options 1.46 STOCK OPTIONS 30 Inference Long Build Up PCR F&O Total 0.98 FII Net Activity 186 NNiiffttyy OOppttiioonnss OOII DDiissttrriibbuuttiioonn HIGHLIGHTS: Nifty futures closed at 12384.65 on a positive note with 1.61% increase in open interest indicating Long Build Up. Nifty Futures closed at a premium of 32 points compared to previous day premium of 19 points. BankNifty closed at 31724 on a negative note with 0.19% decrease in open interest indication Long Unwinding. BankNifty Futures closed at a premium of 133 points compared to the previous day premium of 82 points. FII's were Buyers in Index Futures to the tune of 130 crores and were Buyers in Index Options to the tune of 489 crores, Stock Futures were Sellers to the tune of 464 crores. FII's were Net Buyers in derivative segment to the tune of 186 crores. India VIX index is at 14.12.Nifty ATM call option IV is currently at 8.99 whereas Nifty ATM put option IV is quoting at 11.24 NNiiffttyy OOppttiioonnss --CChhaannggee iinn OOII Index options PCR is at 1.46 and F&O Total PCR is at 0.98. Among stock futures TORNTPHARMA, BHARTIAIRTEL, DRREDDY & SRF have witnessed long build up and may show strength in coming session. Stock which witnessed short build up are IDEA, IOC, SBIN & IDFCFIRSTB and may remain weak in coming session. Nifty Put options OI distribution shows that 12000 has highest OI concentration followed by 11500 & 12200 which may act as support for current expiry. Nifty Call strike 12500 followed by 12400 witnessed significant OI concentration and may act as resistance for current expiry. SSEECCUURRIITTIIEESS IINN BBAANN PPEERRIIOODD:: YYEESSBBAANNKK __________________________________________________________________________________________________________________ SSttoocckk FFuuttuurreess -- LLoonngg BBuuiilldd ____________________________________________________________________________________________________________ SSttoocckk FFuuttuurreess -- SShhoorrtt BBuuiilldd UUpp Symbol Fut Price % Chg Open Interest % Chg TORNTPHARM 2016.20 4.22% 387000.00 30.08% BHARTIARTL 498.60 5.43% 55239393.00 9.83% DRREDDY 3045.85 3.23% 3454750.00 8.41% SRF 3638.15 1.37% 849250.00 7.03% Symbol Fut Price % Chg Open Interest % Chg IDEA 4.55 -24.79% 488236000.00 13.46% IOC 122.45 -1.33% 42952000.00 9.99% SBIN 319.50 -1.62% 123102000.00 9.60% IDFCFIRSTB 43.60 -3.65% 236928000.00 5.79% 0 100 200 300 400 11900 12000 12100 12200 12300 12400 12500 12600 12700 12800 x10000 Call_oi Put_oi -60 -40 -20 0 20 40 11900 12000 12100 12200 12300 12400 12500 12600 12700 12800 x10000 Call_chg Put_chg
  • 2. WEEKLY DERIVATIVE REPORT Week ended 17th Jan 2020 NNIIFFTTYY HHIIGGHHLLIIGGHHTTSS::  Nifty Futures has increased by 0.77% to close at 12,384 from previous week close of 12,290.  Nifty annualized volatility index India Vix has increased to 14.13% from 14.08% up by 0.36%.  The total open interest (OI) in the Nifty stood at Rs 7,750cr.Where as stock futures OI is at 50,310cr.  The open interest position of FII in Index Futures is at Rs 13,985Cr and in Stock futures is at Rs 105,171 Cr. Nifty PCR OI  PCR OI has made a high of 1.68 & low of 1.46 and closed on weekly basis at 1.46 levels.  PCR OI currently is at 1.46 levels which is well above the median line indicating that we will see some cautiousness in Nifty from the current levels. OOppeenn IInntteerreesstt AAnnaallyyssiiss  Options Built up Shows that for now nifty has strong support at 12,200 followed by 12,000 and resistance at 12,400 levels followed by 12,500.  12,400 & 12,500 strike call and 12,200 put followed by 12,000 put has highest open interest concentration which suggests that Nifty is likely to trade between this levels. CChhaannggee iinn OOppeenn IInntteerreesstt  This week major addition was seen on the Put front with 12,300 and 12,400 strikes adding 8.09 and 5.09 lakh in OI respectively.  On the Call front we have seen addition at 12,500 strike with increase in OI of 2.09 lakh shares, while unwinding of 3.36 lakh shares was witnessed in 12,200 strike. 1.00 1.10 1.20 1.30 1.40 1.50 1.60 1.70 1.80 2.50 3.50 4.50 5.50 6.50 7.50 6-Jan 7-Jan 8-Jan 9-Jan 10-Jan 13-Jan 14-Jan 15-Jan 16-Jan 17-Jan PUTCALLRATIO OIincr. Call OI Put OI 0 500,000 1,000,000 1,500,000 2,000,000 2,500,000 3,000,000 3,500,000 4,000,000 11800 11900 12000 12100 12200 12300 12400 12500 12600 12700 12800 12900 13000 OpenInterest Open Interest Put OI Call OI -1,000,000 -500,000 0 500,000 1,000,000 11800 11900 12000 12100 12200 12300 12400 12500 12600 12700 12800 12900 13000 OpenInterest Change in Open Interest Call OI Put OI
  • 3. WEEKLY DERIVATIVE REPORT VVoollaattiilliittyy AAnnaallyyssiiss  IV differential between call and put has decreased from last week level, which implies that nifty is most likely to be cautious at higher levels & may trade with positive bias.  Call IV’s currently at 9.84%, while Put IV’s are at 11.34%.  Implied Volatility of option for the current series is at 10.58% and has seen downward trajectory in this week. WWeeeekkllyy PPaarrttiicciippaanntt WWiissee OOppeenn IInntteerreesstt Participant FUT IDX Long (contracts) Net Chg FUT IDX Short (contracts) Net Chg Client 125,224 4,416 114,511 -12,696 DII 44,871 -1,468 41,378 7,735 FII 80,919 -2,528 79,939 7,724 Pro 16,849 -1,942 32,035 -4,285 Participant FUT STK Long (contracts) Net Chg FUT STK Short (contracts) Net Chg Client 756,642 41,355 226,489 15,612 DII 25,488 4,197 1,098,684 2,393 FII 1,017,874 19,278 525,550 40,531 Pro 164,649 18,171 113,930 24,465 FFIIII IInnddeexx FFuuttuurreess  FII activity in the index futures had been mostly on the Sell side during this week.  FII have been net Seller in Index future to the tune of 1231 crore during this week. FFIIII SSttoocckk FFuuttuurreess  FII activity in Stock futures had been on the Sell side during the last week.  This week FII have been net Sellers in stock future segment to the tune 1333 crore. 8.50 9.50 10.50 11.50 12.50 13.50 14.50 15.50 16.50 17.50 6-Jan- 20 7-Jan- 20 8-Jan- 20 9-Jan- 20 10-Jan- 20 13-Jan- 20 14-Jan- 20 15-Jan- 20 16-Jan- 20 17-Jan- 20 Implied volatility(IV) IV Call Iv Put Historic volatility 152,000 154,000 156,000 158,000 160,000 162,000 164,000 13-Jan 14-Jan 15-Jan 16-Jan 17-Jan -1,000 -800 -600 -400 -200 0 200 400 InCrores NET AMT OI IN CONTRACT 1,460,000 1,470,000 1,480,000 1,490,000 1,500,000 1,510,000 1,520,000 1,530,000 1,540,000 1,550,000 13-Jan 14-Jan 15-Jan 16-Jan 17-Jan -1,000 -800 -600 -400 -200 0 200 400 InCrores NET AMT OI IN CONTRACT
  • 4. WEEKLY DERIVATIVE REPORT SSeeccttoorr WWiissee OOppeenn IInntteerreesstt AAnndd PPrriiccee DDaattaa WWeeeekkllyy PPrriiccee CChhaannggee WWeeeekkllyy OOII CChhaannggee WWeeeekkllyy PPCCRR CChhaannggee WWeeeekkllyy OOppeenn IInntteerreesstt GGaaiinneerr WWeeeekkllyy OOppeenn IInntteerreesstt LLoosseerr Script ID Price % Chg OI Futures % Chg NTPC 121.15 0.75% 54835200 75.35% TORNTPHARM 2016.2 5.88% 387000 60.91% INDUSINDBK 1357.2 -9.21% 17051200 51.27% RAMCOCEM 823.3 0.30% 1603200 48.01% TATAGLOBAL 382 11.70% 12673800 39.00% Script ID Price % Chg OI Futures % Chg NMDC 130.05 7.13% 21924000 -19.46% BEL 108.8 11.48% 28902000 -11.04% JUBLFOOD 1752.05 1.47% 2667000 -9.16% AMARAJABAT 785.3 6.36% 1446400 -8.13% HINDUNILVR 2063.45 5.08% 9742500 -7.30% WWeeeekkllyy PPrriiccee GGaaiinneerr WWeeeekkllyy PPrriiccee LLoosseerr Script ID Price % Chg OI Futures % Chg MGL 1142.35 13.44% 2281200 6.95% IGL 471.15 12.88% 9894500 16.40% PEL 1634.55 12.43% 5478879 18.97% TATAGLOBAL 382 11.70% 12673800 39.00% BEL 108.8 11.48% 28902000 -11.04% Script ID Price % Chg OI Futures % Chg IDEA 4.55 -25.41% 488236000 12.36% INFRATEL 219 -11.76% 14692000 7.73% INDUSINDBK 1357.2 -9.21% 17051200 51.27% YESBANK 37.75 -6.79% 305685600 17.35% MOTHERSUMI 140.25 -5.94% 32245000 -0.75% 0.06% 1.69% -1.86% 6.94% 2.46% 0.52% 3.46% 3.11% 2.27% 2.56% 3.07% 4.61% 4.12% 1.96% 2.11% 0.15% 4.75% 3.40% 8.49% Wkly Price change Textile Fertilisers Oil_Gas Cement Capital_Good s Media FMCG Pharma Automobile Infrastructure Finance Others Power Metals Technology Realty Banking Telecom Index 0.70% 21.31% 5.63% 4.37% 4.50% 2.47% 20.62% 6.95% 3.58% 7.26% 2.50% 10.70% 5.16% 4.17% 3.48% 3.28% 5.26% 6.12% 11.91% Wkly OI change Textile Fertilisers Oil_Gas Cement Capital_Good s Media FMCG Pharma Automobile Infrastructure Finance Others Power Metals Technology Realty Banking Telecom Index 1.33% 3.01% 3.02% 2.39% 0.76% 2.13% 0.51% 1.44% 1.12% 1.23% 1.39% 1.53% 1.68% 0.34% 2.19% 0.63% 2.70% 1.17% 2.09% Wkly Roll Over change Textile Fertilisers Oil_Gas Cement Capital_Good s Media FMCG Pharma Automobile Infrastructure Finance Others Power Metals Technology Realty Banking Telecom Index
  • 5. WEEKLY DERIVATIVE REPORT SSttoocckk wwiissee OOppeenn IInntteerreesstt DDiissttrriibbuuttiioonn iinn BBaannkkiinngg SSeeccttoorr BBaannkk NNiiffttyy OOppeenn IInntteerreesstt ffoorr PPSSUU BBaannkkss VV//ss PPrriivvaattee BBaannkkss BBaannkk NNiiffttyy SSttrriikkee wwiissee ooppeenn iinntteerreesstt ddiissttrriibbuuttiioonn RBLBANK, ICICIBANK and INDUSINDBNK can see some NEGATIVE move in this week. Bank Nifty has a very strong support at 31,500, as 31,500 PE strike is having highest OI concentration followed by 31,000 and on the Call front 32,000 CE strike has highest OI concentration indicating strong resistance level followed by 32,500. AXISBANK BANKBARODA CANBK FEDERALBNK HDFCBANK ICICIBANK IDFCFIRSTB INDUSINDBKKOTAKBANK PNB, 10% RBLBANK SBIN, 11% YESBANK 29% 71% Open Interest Psu Bank Private Bank 0 100,000 200,000 300,000 400,000 500,000 600,000 30600 30700 30800 30900 31000 31100 31200 31300 31400 31500 31600 31700 31800 31900 32000 32100 32200 32300 32400 32500 32600 OpenInterest Open Interest Call OI Put OI
  • 6. WEEKLY DERIVATIVE REPORT Disclosures: The following Disclosures are being made in compliance with the SEBI Research Analyst Regulations 2014 (herein after referred to as the Regulations). 1. Axis Securities Ltd. (ASL) is a SEBI Registered Research Analyst having registration no. INH000000297. ASL, the Research Entity (RE) as defined in the Regulations, is engaged in the business of providing Stock broking services, Depository participant services & distribution of various financial products. ASL is a subsidiary company of Axis Bank Ltd. Axis Bank Ltd. is a listed public company and one of India’s largest private sector bank and has its various subsidiaries engaged in businesses of Asset management, NBFC, Merchant Banking, Trusteeship, Venture Capital, Stock Broking, the details in respect of which are available on www.axisbank.com. 2. ASL is registered with the Securities & Exchange Board of India (SEBI) for its stock broking & Depository participant business activities and with the Association of Mutual Funds of India (AMFI) for distribution of financial products and also registered with IRDA as a corporate agent for insurance business activity. 3. ASL has no material adverse disciplinary history as on the date of publication of this report. 4. I/We, authors (Research team) and the name/s subscribed to this report, hereby certify that all of the views expressed in this research report accurately reflect my/our views about the subject issuer(s) or securities. I/We also certify that no part of my/our compensation was, is, or will be directly or indirectly related to the specific recommendation(s) or view(s) in this report. I/we or my/our relative or ASL does not have any financial interest in the subject company. Also I/we or my/our relative or ASL or its Associates may have beneficial ownership of 1% or more in the subject company at the end of the month immediately preceding the date of publication of the Research Report. Since associates of ASL are engaged in various financial service businesses, they might have financial interests or beneficial ownership in various companies including the subject company/companies mentioned in this report. I/we or my/our relative or ASL or its associate does not have any material conflict of interest. I/we have not served as director / officer, etc. in the subject company in the last 12- month period. Research Team Sr. No Name Designation E-mail 1 Rajesh Palviya Technical & DerivativeAnalyst - (Head) rajesh.palviya@axissecurities.in 2 Vaishnavi Jagtap Technical Analyst vaishnavi.jagtap@axissecurities.in 3 Hemang Gor Derivative Analyst hemang.gor@axissecurities.in 4 Rahil.vora Derivative Analyst Rahil.vora@axissecurities.in 5 Hiren Trivedi Research Associate hiren.trivedi@axissecurities.in 6 Kiran Gawle Associate kiran.gawle@axissecurities.in 5. ASL has not received any compensation from the subject company in the past twelve months. ASL has not been engaged in market making activity for the subject company. 6. In the last 12-month period ending on the last day of the month immediately preceding the date of publication of this research report, ASL or any of its associates may have: i. Received compensation for investment banking, merchant banking or stock broking services or for any other services from the subject company of this research report and / or; ii. Managed or co-managed public offering of the securities from the subject company of this research report and / or; iii. Received compensation for products or services other than investment banking, merchant banking or stock broking services from the subject company of this research report; ASL or any of its associates have not received compensation or other benefits from the subject company of this research report or any other third-party in connection with this report Term& Conditions: This report has been prepared by ASL and is meant for sole use by the recipient and not for circulation. The report and information contained herein is strictly confidential and may not be altered in any way, transmitted to, copied or distributed, in part or in whole, to any other person or to the media or reproduced in any form, without prior written consent of ASL. The report is based on the facts, figures and information that are considered true, correct, reliable and accurate. The intent of this report is not recommendatory in nature. The information is obtained from publicly available media or other sources believed to be reliable. Such information has not been independently verified and no guaranty, representation of warranty, express or implied, is made as to its accuracy, completeness or correctness. All such information and opinions are subject to change without notice. The report is prepared solely for informational purpose and does not constitute an offer document or solicitation of offer to buy or sell or subscribe for securities or other financial instruments for the clients. Though disseminated to all the customers simultaneously, not all customers may receive this report at the same time. ASL will not treat recipients as customers by virtue of their receiving this report.
  • 7. WEEKLY DERIVATIVE REPORT Disclaimer: Nothing in this report constitutes investment, legal, accounting and tax advice or a representation that any investment or strategy is suitable or appropriate to the recipient’s specific circumstances. The securities and strategies discussed and opinions expressed, if any, in this report may not be suitable for all investors, who must make their own investment decisions, based on their own investment objectives, financial positions and needs of specific recipient. This report may not be taken in substitution for the exercise of independent judgment by any recipient. Each recipient of this report should make such investigations as it deems necessary to arrive at an independent evaluation of an investment in the securities of companies referred to in this report (including the merits and risks involved), and should consult its own advisors to determine the merits and risks of such an investment. Certain transactions, including those involving futures, options and other derivatives as well as non-investment grade securities involve substantial risk and are not suitable for all investors. ASL, its directors, analysts or employees do not take any responsibility, financial or otherwise, of the losses or the damages sustained due to the investments made or any action taken on basis of this report, including but not restricted to, fluctuation in the prices of shares and bonds, changes in the currency rates, diminution in the NAVs, reduction in the dividend or income, etc. Past performance is not necessarily a guide to future performance. Investors are advise necessarily a guide to future performance. Investors are advised to see Risk Disclosure Document to understand the risks associated before investing in the securities markets. Actual results may differ materially from those set forth in projections. Forward-looking statements are not predictions and may be subject to change without notice. ASL and its affiliated companies, their directors and employees may; (a) from time to time, have long or short position(s) in, and buy or sell the securities of the company(ies) mentioned herein or (b) be engaged in any other transaction involving such securities or earn brokerage or other compensation or act as a market maker in the financial instruments of the company(ies) discussed herein or act as an advisor or investment banker, lender/borrower to such company(ies) or may have any other potential conflict of interests with respect to any recommendation and other related information and opinions. Each of these entities functions as a separate, distinct and independent of each other. The recipient should take this into account before interpreting this document. ASL and / or its affiliates do and seek to do business including investment banking with companies covered in its research reports. As a result, the recipients of this report should be aware that ASL may have a potential conflict of interest that may affect the objectivity of this report. Compensation of Research Analysts is not based on any specific merchant banking, investment banking or brokerage service transactions. ASL may have issued other reports that are inconsistent with and reach different conclusion from the information presented in this report. Neither this report nor any copy of it may be taken or transmitted into the United State (to U.S. Persons), Canada, or Japan or distributed, directly or indirectly, in the United States or Canada or distributed or redistributed in Japan or to any resident thereof. If this report is inadvertently sent or has reached any individual in such country, especially, USA, the same may be ignored and brought to the attention of the sender. This report is not directed or intended for distribution to, or use by, any person or entity who is a citizen or resident of or located in any locality, state, country or other jurisdiction, where such distribution, publication, availability or use would be contrary to law, regulation or which would subject ASL to any registration or licensing requirement within such jurisdiction. The securities described herein may or may not be eligible for sale in all jurisdictions or to certain category of investors. The Disclosures of Interest Statement incorporated in this document is provided solely to enhance the transparency and should not be treated as endorsement of the views expressed in the report. The Company reserves the right to make modifications and alternations to this document as may be required from time to time without any prior notice. The views expressed are those of the analyst(s) and the Company may or may not subscribe to all the views expressed therein. Copyright in this document vests with Axis Securities Limited. Axis Securities Limited, SEBI Single Reg. No.- NSE, BSE & MSEI – INZ000161633, ARN No. 64610, CDSL-IN-DP-CDSL-693-2013, SEBI- Research Analyst Reg. No. INH 000000297, SEBI Portfolio Manager Reg. No.- INP000000654, Main/Dealing off.- Unit No. 2, Phoenix Market City, 15, LBS Road, Near Kamani Junction, Kurla (west), Mumbai-400070, Tel No. – 18002100808, Reg. off.- Axis House, 8th Floor, Wadia International Centre, Pandurang Budhkar Marg, Worli, Mumbai – 400 025.Compliance Officer: Anand Shaha, E-Mail ID: compliance.officer@axisdirect.in,Tel No: 022-42671582.